Percutaneous mitral annuloplasty with the Mitralign Bident system successfully reduced mitral regurgitant volume from 49 mL to 10 mL and effective regurgitant orifice area from 0.3 cm2 to 0.1 cm2.
Case Report (n=1)
Does percutaneous direct mitral annuloplasty using the Mitralign Bident system improve echocardiographic parameters in a patient with functional mitral regurgitation and heart failure?
Percutaneous direct mitral annuloplasty using the Mitralign Bident system is feasible and can reduce functional mitral regurgitation in a patient with dilated cardiomyopathy.
BACKGROUND: Functional mitral regurgitation (FMR) is known to contribute to a poor prognosis in patients with heart failure (HF). Current guidelines do not recommend cardiac surgery in patients with FMR and impaired ejection fraction due to the high procedural risk. Percutaneous techniques aimed at mitral valve repair may constitute an alternative to currently used routine medical treatment. AIM: To provide a description of a novel percutaneous suture-based technique of direct mitral annuloplasty using the Mitralign Bident system, as well as report our first case successfully treated with this method. METHODS: A deflectable guiding catheter is advanced via the femoral route across the aortic valve to the posterior wall of the ventricle. A nested deflectable catheter is advanced through the guide toward the mitral annulus that allows the advancement of an insulated radiofrequency wire to cross the annulus. The wire is directed across the annulus in a target area that is 2-5 mm from the base of the leaflet into the annulus, as assessed by real-time 3D transoesophageal echocardiography. After placement of the first wire, another wire is positioned using a duel lumen bident delivery catheter, which provides a predetermined separation between wires (i.e. 14, 17 or 21 mm). Each wire provides a guide rail for implantation of sutured pledget implants within the annulus. Two pairs of pledgets are implanted, one pair in each of the P1 and P3 scallop regions of the posterior mitral annulus. A dedicated plication lock device is used to provide a means for plication of the annulus within each pair of the pledgets, and to retain the plication by delivering a suture locking implant. The plications result in improved leaflet coaptation and a reduction of the regurgitant orifice area. RESULTS: A 60-year-old female with diagnosed dilated cardiomyopathy, concomitant FMR class III and congestive HF was successfully treated with the Mitralign Bident system. Two pairs of pledgets were implanted resulting in an improvement of transoesophageal echocardiographic parameters, including proximal isovelocity surface area radius (0.7 cm to 0.4 cm), effective regurgitant orfice area (0.3 cm² to 0.1 cm²) and mitral regurgitant volume (49 mL to 10 mL). CONCLUSIONS: Percutaneous mitral annuloplasty with the Mitralign Bident system is feasible. Future clinical trials are needed to assess its safety and efficacy.
Siminiak et al. (2013) conducted a case report in Functional mitral regurgitation and dilated cardiomyopathy (n=1). Percutaneous direct mitral annuloplasty using the Mitralign Bident system vs. Baseline (pre-procedure) was evaluated on Echocardiographic parameters of mitral regurgitation (PISA radius, EROA, mitral regurgitant volume). Percutaneous mitral annuloplasty with the Mitralign Bident system successfully reduced mitral regurgitant volume from 49 mL to 10 mL and effective regurgitant orifice area from 0.3 cm2 to 0.1 cm2.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: